期刊文献+

用尿激酶型纤溶酶原激活物建立兔骨关节炎模型的研究 被引量:22

A Study on uPA-induced Osteoarthritis in Rabbit Knee Joint
暂未订购
导出
摘要 为探讨在兔膝关节腔注射尿激酶型纤溶酶原激活物(urokinase-type plasminogen activator,uPA),建立兔膝关节骨关节炎动物模型的可行性。选择健康新西兰大白兔42只并随机分为实验组和对照组,实验组24只,对照组18只;实验组在右膝关节内注射uPA0.4μg/0.2mL,对照组注射等容量的生理盐水,注射完成后在4周、8周、12周分批取兔滑膜进行组织学观察、取软骨行组织学观察及电镜检查。结果显示:实验组兔膝关节滑膜均存在不同程度增生、肥厚、水肿,光镜及电镜下见实验组关节软骨呈明显退行性变。Mankin’s评分实验组得分显著高于对照组(P<0.05)。结论:兔膝关节注射uPA可使滑膜发生炎症、关节软骨发生退变,而且随着时间退变的程度逐渐加重,这一模型可为研究膝关节OA的病因、发病机理及治疗方法提供实验工具。 The aim of this study was to set up an animal model of osteoarthritis (OA) in the rabbit joint. Methods 42 white rabbits were devided into experimental animals and control animals. The experimental animals were injected intraarticularly with 0.4μg,/0.2mL uPA, and control animals were injected with the same doses of normal saline. All animals were sacrificed 4,8,12 weeks respectively after the injections. The synovial tissue and the articular cartilage were pathologically examined. Results: The synovium of knee joint in the experimental group were found adhensive, swelling and overgrowth. Obvious degenerative change were found in the experimental group by microscope. The experimental group score was significantly higher than that of the compared group according to Mankin' s stantard ( P 〈 0.05 ). Conclusion uPA may be responsible for the inflammation of synovium and degeneration of articular cartilage, and the degree of the degeneration was gradually aggravated by the extension of time. This animal model can be used for exploring pathogenisis of osteoarthritis and selecting treatments for this disease.
出处 《石河子大学学报(自然科学版)》 CAS 2006年第1期66-69,共4页 Journal of Shihezi University(Natural Science)
关键词 尿激酶型纤溶酶原激活物 骨关节炎 模型 urokinase-type plasminogen activator~ osteoarthritis animal model
  • 相关文献

参考文献9

  • 1李茂强,史晨辉,李宽新,胡文浩,王永明,刘维钢,董金波,李洪安.骨关节炎滑膜uPA,uPAR,tPA表达及意义[J].中国矫形外科杂志,2004,12(21):1686-1688. 被引量:16
  • 2Mankin H J,Dorfman H.Biochemical and metabolic abnormaliaties in articular cartilage from Osteoarthritic human hips[J].J Bone Jt.Surg(Am),1971,53:523-537.
  • 3邹季.骨科实验动物模型的选择与有关问题.中华实验外科杂志,1992,9(4):18-18.
  • 4聂林.骨关节炎的动物模型[J].中华实验外科杂志,1990,7(2):96-97. 被引量:58
  • 5肖继平,张广德,夏文华,陈德基.尿激酶型纤溶酶原激活物在乳腺癌中的表达及意义[J].中华肿瘤杂志,1999,21(3):196-198. 被引量:9
  • 6Del Rosso M,Fibbi G,et al.The urokinase-type plasminogen activator system and inflammatory joint diseases[J].Clin Exp Rheumatol,1999,17:485-498.
  • 7Nakano S,Ikata T,et al.Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis[J].Clin Exp Rheumatol,1999,17:161-170.
  • 8姚如愚,张晓.基质金属蛋白酶与骨关节炎[J].国外医学(内科学分册),2001,28(4):159-162. 被引量:29
  • 9Pelletier J P.Imbanlance between the mechanisms of activation and inhibition of metalloproteases in the early leasions of experimental osteoarthrisitis[J].Arthritis Rheum,1990,33:364-367.

二级参考文献21

  • 1[12]Horton WE Jr, Udo I, Precht P, et al.[J]. In Vitro Cell Dev Biol Anim, 1998,34(5) :378-384.
  • 2[13]Su S, Grover J, Roughley PJ, et al.[J]. Rheumatol Int, 1999,18(5-6): 183-191.
  • 3[14]Frenkel SR,Saadeh PB,Mehrara BJ,et al.[J]. Plast Reconstr Surg,2000,105(3) :980-990.
  • 4[15]Skotnicki JS,Zask A,Nelson FC,et al.[J]. Ann NY Acad Sci, 1999,878:61-72.
  • 5[1]Brama PA,Tekoppele JM,Beekman B,et al.[J]. Ann Rheum Dis, 1998,57: 697-699.
  • 6[2]Smith RL,Trindade MC,Ikenoue T,et al.[J]. Biorheology,2000,37(1-2) :95-107.
  • 7[3]Dahlberg L, Billinghurst RC, Manner P, et al.[ J].Arthritis Rheum,2000,43(3) :673-682.
  • 8[4]Freemont AJ, Byers RJ, Taiwo YO, et al.[J]. Ann Rheum Dis, 1999,58(6) :357-365.
  • 9[5]Eyre DR.[J]. Semin Arthritis Rheum, 1991,21 (3Suppl 2) :2-11.
  • 10[6]Mehraban F, Lark MV, Ahmed FN, et al.[J]. Osteoarthritis Cartilage, 1998,6(4) :286-294.

共引文献107

同被引文献447

引证文献22

二级引证文献331

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部